VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions for large disease areas of high unmet medical need. By combining state-of-the-art technologies and novel and scientific concepts, VectorY’s mission is to bring innovative therapies to patients worldwide.

Biotechnology

VectorY

Sander Van Deventer

Michael Wyzga

Wouter Pos

Claus Sundgreen

Sandra Lemmens

Rob Haselberg

Raygene Martier, PhD

Marco Boorsma

Femke Hoeksema

Elena Ritsou

Barbara Sanders

André Verwei

Pavlina Konstantinova

Advisory and Board Members

Scientific and Technical Team

Leadership Team

Management and Finance

Teams at VectorY

Advisory and Board Members

Scientific and Technical Team

Leadership Team

Management and Finance